Future Market Insights (FMI), a leading provider of market intelligence and consulting services, today released its comprehensive report on the demand for empty capsules in the European Union. The analysis forecasts the EU empty capsules market to expand from USD 925.1 million in 2025 to USD 2,111.0 million by 2035, achieving a compelling compound annual growth rate (CAGR) of 8.6%. This represents an absolute dollar opportunity of USD 1,176.3 million and a near-doubling of the market size over the decade.

The report highlights the EU's pivotal role in global pharmaceutical and nutraceutical innovation, where empty capsules serve as essential components for oral solid dosage forms. With pharmaceutical contract manufacturing surging across the region and dietary supplement consumption on the rise, demand for high-quality, reliable capsule shells is accelerating. The market is poised to grow by nearly 2.3 times its current size, driven by advancements in capsule technology and shifting consumer preferences toward clean-label and vegetarian options.

Read Full Report-https://www.futuremarketinsights.com/reports/demand-for-empty-capsules-in-eu

"Europe's pharmaceutical ecosystem continues to demonstrate resilience and innovation, positioning the empty capsules segment as a cornerstone of drug delivery and supplement formulation," said a senior analyst at Future Market Insights. "The projected 8.6% CAGR reflects not only steady historical growth but also emerging opportunities in specialized capsule designs that enhance bioavailability, patient compliance, and targeted release profiles."

Key insights from the report underscore several transformative trends shaping the industry. Gelatin-based capsules currently dominate with a 60.2% market share in 2025, valued for their proven dissolution characteristics, cost-effectiveness, and manufacturing maturity. However, vegetarian-based alternatives—such as those derived from hydroxypropyl methylcellulose (HPMC), pullulan, and starch—are gaining significant traction, addressing cultural dietary needs, clean-label demands, and regulatory preferences. This shift is expected to see gelatin's share gradually decline to 52.0% by 2035, while plant-based options capture growing adoption in both pharmaceutical and nutraceutical applications.

Oral administration remains the preferred route, commanding 87.4% of the market in 2025 and projected to hold 85.0% by 2035. This dominance is fueled by the capsules' advantages in patient acceptance, ease of swallowing, and formulation flexibility for controlled-release and enteric-coated products.

Regionally, the EU market exhibits balanced yet differentiated growth. Germany leads with a 27.0% share in 2025, supported by its robust pharmaceutical infrastructure and contract manufacturing hubs, registering a solid 8.2% CAGR. The "Rest of Europe" category matches Germany at 27.0%, with the highest regional CAGR of 9.0%, reflecting emerging manufacturing centers. France follows at 18.0% share and 8.8% CAGR, bolstered by biopharmaceutical development and contract services. Italy (12.0% share, 8.4% CAGR), Spain (10.0% share, 8.6% CAGR), and the Netherlands (6.0% share, 9.2% CAGR) round out the major contributors, with the Netherlands showcasing the fastest expansion due to innovation in clinical trials and pharmaceutical services.

Leading players are capitalizing on these dynamics through strategic investments in capacity and technology. Lonza (Capsugel) holds an estimated 20.0% market share, leveraging its extensive European footprint and expertise in high-quality capsule production. Qualicaps follows with approximately 14.0%, emphasizing pharmaceutical-grade solutions from its Spanish base. ACG (9.0% share), Roxlor (8.0% share in France), and Suheung (5.0% share) further strengthen the competitive landscape, alongside a diverse array of regional specialists comprising 44.0% of the market.

Subscribe for Year-Round Insights → Stay ahead with quarterly and annual data updates: https://www.futuremarketinsights.com/reports/brochure/rep-gb-27156

Request for Discount: https://www.futuremarketinsights.com/reports/sample/rep-gb-27156

The report identifies key growth drivers, including the expansion of contract manufacturing for clinical trials and commercial production, scientific validation of capsule performance in bioavailability enhancement, and rising demand for specialized technologies like delayed-release and modified-release capsules. Opportunities abound in vegetarian capsule innovations and integration with advanced drug delivery systems.

Challenges such as raw material volatility for gelatin and regulatory adaptations are noted, yet the overall outlook remains optimistic. As European manufacturers prioritize quality assurance, regulatory compliance, and sustainable materials, the empty capsules market is set to play an instrumental role in advancing healthcare outcomes across the continent.

This in-depth analysis equips industry stakeholders—pharmaceutical companies, nutraceutical producers, contract manufacturers, and investors—with decision-grade insights to navigate this evolving landscape. The full report, "Demand for Empty Capsules in EU: Size and Share Forecast Outlook 2025 to 2035," is available now.

Explore More Related Studies Published by FMI Research:

Absorbable PGLA Surgical Sutures Market- https://www.futuremarketinsights.com/reports/absorbable-pgla-surgical-sutures-market

Absorbable Surgical Suture with Needle Market- https://www.futuremarketinsights.com/reports/absorbable-surgical-suture-with-needle-market

Absorbable PGA Surgical Sutures Market- https://www.futuremarketinsights.com/reports/absorbable-pga-surgical-sutures-market

3D Ready Organoid Expansion Service Market- https://www.futuremarketinsights.com/reports/3d-ready-organoid-expansion-service-market

Chronic Sarcoidosis Therapeutics Market- https://www.futuremarketinsights.com/reports/chronic-sarcoidosis-therapeutics-market

About Future Market Insights (FMI)

 Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.

Why FMI: Decisions that Change Outcomes- https://www.futuremarketinsights.com/why-fmi

Contact Us:    

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Have a specific Requirements and Need Assistant on Report Pricing or Limited Budget please contact us - sales@futuremarketinsights.com